KIT and gastrointestinal stromal tumor: And phosphorothioation and 2′-O-methylation of miRNA-221 and miRNA-222 in GIST cells were reported to effectively inhibit KIT expression, thus affecting various cellular processes mediated by KIT, including resistance of imatinib (Durso et al., 2016).